Xylo Technologies Ltd. (XYLO)

Market Cap	3.06M
Revenue (ttm)	91.72M
Net Income (ttm)	-16.03M
Shares Out	2.35M
EPS (ttm)	-9.45
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,999
Open	1.650
Previous Close	1.650
Day's Range	1.620 - 1.730
52-Week Range	1.540 - 7.170
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About XYLO

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusio...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 77
• Stock Exchange: NASDAQ
• Ticker Symbol: XYLO

Financial Performance

In 2023, XYLO's revenue was $91.72 million, a decrease of -0.15% compared to the previous year's $91.86 million. Losses were -$16.03 million, 63.3% more than in 2022.

Financial numbers in USD